European Organisation for Research and Treatment of Cancer @eortc.org · Jun 26 1 / 2
At #6WCCL, Pablo L. Ortiz-Romero presents a poster on EORTC 1820 MOGAT. Interim data show sequential mogamulizumab + TSEB is tolerable in early-stage MF. Final results will assess progression-free outcomes. 👏 Congrats to all contributors. #6WCCL #EORTCcutanouslymphoma
0 likes 0 replies
?